Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regencell Bioscience Holdings Ltd
(NQ:
RGC
)
6.020
+0.110 (+1.86%)
Streaming Delayed Price
Updated: 11:20 AM EST, Nov 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Regencell Bioscience Holdings Ltd
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial
September 12, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
May 18, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
May 16, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network
March 01, 2022
LOS ANGELES, CA / ACCESSWIRE / March 1, 2022 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with the team from Regencell Bioscience Holdings...
From
Stock News Now
Via
AccessWire
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
February 16, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors
December 13, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO
November 22, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index
November 22, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment
September 02, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option
August 20, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders
August 05, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering
July 20, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
July 15, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.